Tissue | Expression Dynamics | Abbreviation |
Breast | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Breast/PPP1R1B_pca_on_diff_genes.png) | IDC: Invasive ductal carcinoma |
DCIS: Ductal carcinoma in situ |
Precancer(BRCA1-mut): Precancerous lesion from BRCA1 mutation carriers |
Colorectum (GSE201348) | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Colorectum/Becker/PPP1R1B_pca_on_diff_genes.png) | FAP: Familial adenomatous polyposis |
CRC: Colorectal cancer |
Colorectum (HTA11) | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Colorectum/Chen/PPP1R1B_pca_on_diff_genes.png) | AD: Adenomas |
SER: Sessile serrated lesions |
MSI-H: Microsatellite-high colorectal cancer |
MSS: Microsatellite stable colorectal cancer |
Esophagus | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Esophagus/PPP1R1B_pca_on_diff_genes.png) | ESCC: Esophageal squamous cell carcinoma |
HGIN: High-grade intraepithelial neoplasias |
LGIN: Low-grade intraepithelial neoplasias |
GC | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/GC/PPP1R1B_pca_on_diff_genes.png) | CAG: Chronic atrophic gastritis |
CAG with IM: Chronic atrophic gastritis with intestinal metaplasia |
CSG: Chronic superficial gastritis |
GC: Gastric cancer |
SIM: Severe intestinal metaplasia |
WIM: Wild intestinal metaplasia |
Liver | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Liver/PPP1R1B_pca_on_diff_genes.png) | HCC: Hepatocellular carcinoma |
NAFLD: Non-alcoholic fatty liver disease |
Prostate | ![The image shows the transcriptomic changes along malignancy continuum.log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage.](images/deg_images/Prostate/PPP1R1B_pca_on_diff_genes.png) | BPH: Benign Prostatic Hyperplasia |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:005134617 | Prostate | Tumor | negative regulation of hydrolase activity | 97/3246 | 379/18723 | 2.87e-05 | 3.46e-04 | 97 |
GO:003530419 | Prostate | Tumor | regulation of protein dephosphorylation | 31/3246 | 90/18723 | 6.77e-05 | 7.21e-04 | 31 |
GO:004366616 | Prostate | Tumor | regulation of phosphoprotein phosphatase activity | 22/3246 | 58/18723 | 1.53e-04 | 1.39e-03 | 22 |
GO:003530318 | Prostate | Tumor | regulation of dephosphorylation | 39/3246 | 128/18723 | 1.82e-04 | 1.60e-03 | 39 |
GO:000931415 | Prostate | Tumor | response to radiation | 109/3246 | 456/18723 | 1.94e-04 | 1.70e-03 | 109 |
GO:001092113 | Prostate | Tumor | regulation of phosphatase activity | 28/3246 | 84/18723 | 2.80e-04 | 2.28e-03 | 28 |
GO:001631113 | Prostate | Tumor | dephosphorylation | 98/3246 | 417/18723 | 7.31e-04 | 5.08e-03 | 98 |
GO:00719011 | Prostate | Tumor | negative regulation of protein serine/threonine kinase activity | 35/3246 | 120/18723 | 9.20e-04 | 6.08e-03 | 35 |
GO:000197511 | Prostate | Tumor | response to amphetamine | 13/3246 | 33/18723 | 2.26e-03 | 1.28e-02 | 13 |
GO:00508901 | Prostate | Tumor | cognition | 69/3246 | 296/18723 | 5.03e-03 | 2.45e-02 | 69 |
GO:001407512 | Prostate | Tumor | response to amine | 16/3246 | 49/18723 | 6.74e-03 | 3.07e-02 | 16 |
GO:00513466 | Stomach | GC | negative regulation of hydrolase activity | 51/1159 | 379/18723 | 1.38e-07 | 8.14e-06 | 51 |
GO:00513486 | Stomach | GC | negative regulation of transferase activity | 36/1159 | 268/18723 | 9.70e-06 | 3.27e-04 | 36 |
GO:00064696 | Stomach | GC | negative regulation of protein kinase activity | 27/1159 | 212/18723 | 2.93e-04 | 4.70e-03 | 27 |
GO:00459366 | Stomach | GC | negative regulation of phosphate metabolic process | 46/1159 | 441/18723 | 3.71e-04 | 5.73e-03 | 46 |
GO:00105636 | Stomach | GC | negative regulation of phosphorus metabolic process | 46/1159 | 442/18723 | 3.90e-04 | 5.97e-03 | 46 |
GO:0009314 | Stomach | GC | response to radiation | 47/1159 | 456/18723 | 4.21e-04 | 6.33e-03 | 47 |
GO:00336735 | Stomach | GC | negative regulation of kinase activity | 28/1159 | 237/18723 | 7.74e-04 | 9.90e-03 | 28 |
GO:00019336 | Stomach | GC | negative regulation of protein phosphorylation | 36/1159 | 342/18723 | 1.31e-03 | 1.46e-02 | 36 |
GO:00423266 | Stomach | GC | negative regulation of phosphorylation | 39/1159 | 385/18723 | 1.72e-03 | 1.81e-02 | 39 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
PPP1R1B | SNV | Missense_Mutation | novel | c.524N>G | p.Asp175Gly | p.D175G | Q9UD71 | protein_coding | tolerated_low_confidence(0.26) | probably_damaging(0.925) | TCGA-AC-A6IW-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
PPP1R1B | SNV | Missense_Mutation | novel | c.146N>G | p.Glu49Gly | p.E49G | Q9UD71 | protein_coding | deleterious(0.03) | probably_damaging(0.995) | TCGA-CM-6171-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
PPP1R1B | SNV | Missense_Mutation | | c.33N>A | p.Phe11Leu | p.F11L | Q9UD71 | protein_coding | deleterious(0) | probably_damaging(0.973) | TCGA-EI-6917-01 | Colorectum | rectum adenocarcinoma | Male | <65 | III/IV | Chemotherapy | 5fluorouracil+oxaciplatina+l-folinian | SD |
PPP1R1B | deletion | Frame_Shift_Del | novel | c.287_290delNNNN | p.Asn97ArgfsTer45 | p.N97Rfs*45 | Q9UD71 | protein_coding | | | TCGA-5M-AAT4-01 | Colorectum | colon adenocarcinoma | Male | >=65 | III/IV | Unknown | Unknown | PD |
PPP1R1B | SNV | Missense_Mutation | novel | c.169N>A | p.Ala57Thr | p.A57T | Q9UD71 | protein_coding | tolerated(0.31) | benign(0.01) | TCGA-A5-A0GG-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
PPP1R1B | SNV | Missense_Mutation | rs200974893 | c.197N>T | p.Ser66Leu | p.S66L | Q9UD71 | protein_coding | tolerated(0.12) | benign(0.355) | TCGA-AP-A059-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
PPP1R1B | SNV | Missense_Mutation | | c.33C>A | p.Phe11Leu | p.F11L | Q9UD71 | protein_coding | deleterious(0) | probably_damaging(0.973) | TCGA-B5-A0JY-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | doxorubicin | SD |
PPP1R1B | SNV | Missense_Mutation | novel | c.430N>A | p.Val144Ile | p.V144I | Q9UD71 | protein_coding | tolerated_low_confidence(0.68) | benign(0.001) | TCGA-E6-A2P9-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
PPP1R1B | SNV | Missense_Mutation | novel | c.429N>T | p.Lys143Asn | p.K143N | Q9UD71 | protein_coding | deleterious_low_confidence(0.01) | probably_damaging(0.997) | TCGA-EO-A22R-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
PPP1R1B | SNV | Missense_Mutation | rs367543179 | c.86N>T | p.Arg29Leu | p.R29L | Q9UD71 | protein_coding | deleterious(0) | probably_damaging(0.995) | TCGA-EO-A3AU-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |